Език: EN EN
← Назад към резултатите
Набира участници NCT03611816

Biological Bank for Atrial Fibrillation and Stroke

Заболявания: Stroke Atrial Fibrillation

Спонсор: Hospices Civils de Lyon

Налично на: БГ
Обобщение
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. This arrhythmia is responsible for 15% of strokes and more than 30% of strokes on people over 65 years. According to studies, 30 to 40% of isolated atrial fibrillations could be familial. Atrial fibrillation has significant genetic heterogeneity. About 40 genes have been identified as potentially involved. Studies have identified genes common to the risk of atrial fibrillation and stroke. Despite the pathophysiology of atrial fibrillation has been intensively and extensively studied for almost a century, there are still many questions. The pathophysiology is not sufficiently understood to allow finding more effective therapies. It is necessary to identify genetic determinants and thus potentially new pharmacological targets more adapted. The establishment of a biological database will test hypotheses concerning the genetic origin and thromboembolic process of atrial fibrillation and associated stroke.
Кой може да участва
Group 1a * Inclusion Criteria : \- AF history * Exclusion Criteria : * No AF history * patient who didn't signed consent Group 1b * Inclusion Criteria : * AF history * Scheduled electrophysiological exploration or AF ablation * Exclusion Criteria : * No AF history * pregnant women * patient who didn't signed consent Group 1c * Inclusion Criteria : * AF/AT history * Stroke history * Exclusion Criteria : * No Stroke history * patient who didn't signed consent Group 2 * Inclusion Criteria : * patient over 80 * ECG: sinusal rhythm * TTE : no left atrial dilatation * Exclusion Criteria : * atrial fibrillation history * TTE : Left atria \>25cm², \> 34m/m2), FEVG \< 50% * ECG : QRS \> 90 ms * cardiac pathologies (excepted hypertension and valvulopathies) * History of stroke and transient ischemic attack * patient who didn't signed consent Group 3 * Inclusion Criteria : * cryptogenic stroke or transient ischemic attack history before 50 yo * No AF history * Exclusion Criteria : * AF history * stroke or transient ischemic attack over 50 yo * patient who didn't signed consent
Интервенции
Blood taken
BIOLOGICAL
Blood taken
GENETIC
Blood taken
GENETIC
Места на провеждане 5
Франция (5)
Service neurologie Centre hospitalier Fleyriat
Bourg-en-Bresse
Service d'urgences Neurovasculaires - service de neurologie vasculaire , Hôpital Pierre Wertheimer
Bron
Service de rythmologie, hôpital cardiologique Louis Pradel
Bron
Service de médecine gériatrique Centre hospitalier Lyon Sud, Groupement hospitalier Sud
Pierre-Bénite
Hôpital des charpennes
Villeurbanne
Технически детайли
Статус
Набира участници
Вид изследване
OBSERVATIONAL
Пол
Мъже и жени
Минимална възраст
18 Years
Здрави доброволци
Не
Начална дата
23.04.2018
Крайна дата
23.04.2033
Регистрационен номер
NCT03611816
Източник
clinicaltrials.gov
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.